Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141699 |
| CAS No | NA |
| Mol.F. | C8H16N2O3 |
| Mol.Wt. | 188.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141700 |
| CAS No | NA |
| Mol.F. | C16H17N5OS |
| Mol.Wt. | 327.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141701 |
| CAS No | NA |
| Mol.F. | C12H10N4OS |
| Mol.Wt. | 258.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141702 |
| CAS No | NA |
| Mol.F. | C18H21ClN5OS |
| Mol.Wt. | 390.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141703 |
| CAS No | NA |
| Mol.F. | C17H19N5O2S |
| Mol.Wt. | 357.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141704 |
| CAS No | NA |
| Mol.F. | C17H17FN4O5 |
| Mol.Wt. | 376.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141705 |
| CAS No | NA |
| Mol.F. | C17H16N4O2 |
| Mol.Wt. | 308.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141706 |
| CAS No | NA |
| Mol.F. | C15H17N3O2 |
| Mol.Wt. | 271.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141707 |
| CAS No | NA |
| Mol.F. | C15H17N3O2 |
| Mol.Wt. | 271.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141708 |
| CAS No | NA |
| Mol.F. | C28H25N7O7 |
| Mol.Wt. | 571.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141709 |
| CAS No | NA |
| Mol.F. | C12H19N3O4 |
| Mol.Wt. | 269.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141710 |
| CAS No | NA |
| Mol.F. | C24H25N7O4 |
| Mol.Wt. | 475.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141711 |
| CAS No | NA |
| Mol.F. | C29H31N7O7 |
| Mol.Wt. | 589.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141712 |
| CAS No | NA |
| Mol.F. | C29H29N7O7 |
| Mol.Wt. | 587.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141713 |
| CAS No | NA |
| Mol.F. | C14H11N5O |
| Mol.Wt. | 265.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141714 |
| CAS No | NA |
| Mol.F. | C9H11N5O2 |
| Mol.Wt. | 221.2 |
| INV STATUS | CUSTOM SYNTHESIS |